Plasma proGRP Concentration is Sensitive and Specific for Discriminating Small Cell Lung Cancer from Nonmalignant Conditions or Non-small Cell Lung Cancer

To date, most clinical data on pro-gastrin-releasing peptide (proGRP) have been based on serum concentrations. This study evaluated the agreement between proGRP levels in fresh serum and plasma in patients with various lung diseases. Pairs of serum and EDTA plasma were collected from 49 healthy indi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Hye-Ran, Oh, In-Jae, Shin, Myung-Geun, Park, Joon-Seok, Choi, Hyun-Jung, Ban, Hee-Jung, Kim, Kyu-Sik, Kim, Young-Chul, Shin, Jong-Hee, Ryang, Dong-Wook, Suh, Soon-Pal
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082113/
https://ncbi.nlm.nih.gov/pubmed/21532852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2011.26.5.625
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars